Literature DB >> 6385016

Cellular immune responses in systemic lupus erythematosus.

G C Tsokos, J E Balow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6385016

Source DB:  PubMed          Journal:  Prog Allergy        ISSN： 0079-6034


× No keyword cloud information.
  11 in total

1.  Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Roman Puliaev; Irina Puliaeva; Charles S Via
Journal:  Clin Immunol       Date:  2018-06-22       Impact factor: 3.969

Review 2.  B cell-cytokine interactions: lessons from clinical immunology.

Authors:  J Farrant; A D Webster
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells.

Authors:  Madhumouli Chatterjee; Katalin Kis-Toth; To-Ha Thai; Cox Terhorst; George C Tsokos
Journal:  Autoimmunity       Date:  2011-01-14       Impact factor: 2.815

4.  An IgG subclass imbalance in connective tissue disease.

Authors:  R A Kay; K J Wood; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

5.  Decreased interleukin 2 inhibitor in sera of patients with autoimmune disorders.

Authors:  J Y Djeu; T Kasahara; J E Balow; G C Tsokos
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

6.  Impaired T-cell activation in patients with systemic lupus erythematosus.

Authors:  S Sierakowski; E J Kucharz; R W Lightfoot; J S Goodwin
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

7.  T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity.

Authors:  B L Bermas; M Petri; D Goldman; B Mittleman; M W Miller; N I Stocks; C S Via; G M Shearer
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

8.  Spontaneous production of B cell growth factors by SLE lymphocytes.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

Review 9.  Mechanisms of the pathogenic autoimmune response in lupus: prospects for specific immunotherapy.

Authors:  S K Datta; C Mohan; A Desai-Mehta
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

10.  Decreased activity of interleukin-2 inhibitor in plasma of patients with systemic lupus erythematosus.

Authors:  E J Kucharz; S Sierakowski; J S Goodwin
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.